共 50 条
- [43] Correction to: Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial Diabetes Therapy, 2021, 12 : 2807 - 2811
- [46] Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study JOURNAL OF DERMATOLOGY, 2023, 50 (11): : 1381 - 1391